Correction to: Drugs 78(7):781--785 (2018) 10.1007/s40265-018-0907-5 {#Sec1}
====================================================================

The article Ibalizumab: First Global Approval, written by Anthony Markham, was originally published Online First without open access. After publication in volume 78, issue 7, pages 781--785 Theratechnologies Inc. requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Theratechnologies Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<http://creativecommons.org/licenses/by-nc/4.0/>), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article was corrected.

The original article can be found online at 10.1007/s40265-018-0907-5.
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